Dyne Therapeutics is a clinical stage biotech concern with just over $700 million of cash on its balance sheet. Learn more ...

The SNU BioTalk 2025 an International Conference, themed "Symphony of Cellular Signals in Metabolism and Immune Response," ...

The transcription factor regulatory network in Pseudomonas aeruginosa is complex and involves multiple regulators that respond to various environmental signals and physiological cues by regulating ...

RNA (ribonucleic acid) is a nucleic acid polymer where the carbohydrate is ribose. RNA is generally single-stranded, as DNA is transcribed by RNA polymerases into mRNA (messenger RNA), which is ...

President Donald Trump announced a $500billion investment for private companies to develop artificial intelligence tools to ...

Inflammatix, a pioneering host response diagnostics company, today announced that the U.S. Food and Drug Administration (FDA) ...

Considering Matrine and Evodiamine are commonly utilized in clinical treatment and the drugs can lead to fatal cardiotoxicity, in this study, we investigated the effects of Matrine and Evodiamine ...

RNA modifications like m6A are vital for gene expression but challenging to detect at single-base resolution. Here, the authors introduce pum6a, an advanced computational framework, to enable ...

Jan. 23, 2025 — Researchers have found that a newly developed diet inspired by the eating habits of non-industrialized societies can significantly reduce the risk of a number of chronic diseases ...

The Graph price prediction anticipates a high of $0.419 by the end of 2025. In 2028, it will range between $0.978 and $1.12, with an average price of $1.05. In 2031, it will range between $1.68 and $1 ...